Occupational exposure – exposure to a medicinal product that a person experiences as a result of both professional activities and other activities. This exposure does not include cases of exposure to one of the ingredients of a medicinal product at the manufacturing stage prior to release as a finished medicinal product.*

*Decision No. 87 of the Council of the Eurasian Economic Commission dated November 3, 2016 “On Approval of the Good Pharmacovigilance Practice Rules of the Eurasian Economic Union” (as amended by Decision No. 81 of the Council of the Eurasian Economic Commission dated May 19, 2022). Effective date — December 6, 2022.